Radius Care — Financial Statements 2026 (FY26)
Radius Residential Care Limited
Provider claim
Community provider
2026-10-10
Next review: 2027-04-10
New Zealand Radius consolidated group; not national sector coverage
Medium confidence
verified
Primary-source research review
Evidence boundary: Historical issuer financial statements for the year ended 31 March 2026, authorised/audited/released 13 May. All 39 original pages reviewed; the annual-report filename is retained as capture provenance, but the full June annual report is a separate 44-spread edition. The live issuer financial PDF is byte-identical to the original. The May NZX attachment has different bytes but identical extracted text on all 39 pages; text equality does not certify identical visual encoding. Publisher access and URL hosting paths do not create a new publication date. Baker Tilly’s financial opinion applies to pp. 2–35 and excludes other information; it does not audit clinical quality, workforce adequacy or all narrative claims. Group and owner profits differ; payroll costs are not headcount; valuation inputs are estimates; lease cash-flow maturity and ORA accounting classifications are not legal deadlines. Page 34 reports lease liabilities $141.517m while pp. 4/17/32 report $141.512m; retain the latter explicitly with references rather than silently reconcile the source. The review does not replicate the valuation model or establish current fees, personal funding eligibility, contractual validity, clinical certification, employment compliance, later projects/acquisitions or service availability. Separate June-report care/workforce narrative and non-GAAP results are not imported as original-package findings.
Short Answer
The retained “FY26 Annual Report” file is actually Radius Residential Care Limited’s 39-page audited financial-statements package for the year ended 31 March 2026, released on 13 May. It records care funding, employee costs, leases, resident liabilities and acquisition accounting; the separate 29 June annual report is a different source.
Why it matters
Use as a historical financial baseline for care funding, payroll cost, property/lease models and resident liability questions. Read the notes alongside the statements and separate group/owner profit, accounting valuation, cash flow and non-GAAP measures. Seek the distinct June annual report for operator care/workforce narrative and independent, current site evidence before making service or safety comparisons.
Key Points
- •Identity: the preserved annual-report filename contains Financial Statements 2026, 39 physical pages; statement pages 2–35 and audit pages 36–39. The distinct full annual report was released 29 June 2026 (separate NZX announcement 475175).
- •Period and dates: year ended 31 March 2026; financial authorisation and Baker Tilly Staples Rodway Auckland audit dated 13 May 2026 (pp. 4, 39). NZX announcement 472508 published 13 May at 08:30 NZST; June 2026 access remains the original capture label.
- •Total group revenue NZ$202.279m versus $177.415m in FY2025 includes $2.181m deferred management fees. Total revenue and other income is a different $205.515m measure (p. 2).
- •FY2026 profit before tax $14.339m; group profit after tax $10.053m; owners $9.457m and non-controlling interests $0.596m. Total comprehensive income $15.783m also includes other comprehensive income (p. 2).
- •Net operating cash inflow $25.121m versus $20.053m; the cash-flow statement includes occupation-right receipts $7.575m and repurchases $4.791m, plus $3.496m income tax paid (pp. 5–6). This is not a disclosed AFFO measure.
- •Rest-home, hospital and dementia fees $175.805m; accommodation supplements $12.156m; village fees $1.272m; external catering revenue $5.791m, all FY2026 consolidated revenue categories (p. 9).
Full Summary & Notes
The retained “FY26 Annual Report” file is actually Radius Residential Care Limited’s 39-page audited financial-statements package for the year ended 31 March 2026, released on 13 May. It records care funding, employee costs, leases, resident liabilities and acquisition accounting; the separate 29 June annual report is a different source.
Open the full summary for detailed notes and source links.
Radius Residential Care Limited’s Financial Statements 2026 consolidate its New Zealand aged-care group for the year ended 31 March 2026. The original has 39 physical pages, including the financial statements on pages 2–35 and Baker Tilly Staples Rodway Auckland’s audit on pages 36–39. Its retained annual-report filename does not identify the full annual report subsequently released on 29 June 2026.
The group reports NZ$202.279 million total revenue, including $2.181 million deferred management fees; $14.339 million profit before tax; and $10.053 million total profit after tax. Profit attributable to owners is $9.457 million, with $0.596 million attributable to non-controlling interests. Operating cash inflow is $25.121 million, and includes retirement-village occupation-right receipts and repurchases. These measures differ from the unaudited AFFO and underlying earnings reported in separate results material.
The revenue note reports $175.805 million rest-home, hospital and dementia fees, $12.156 million accommodation supplements, and $118.1 million Health New Zealand subsidies included in care fees and services. Employee costs are $123.048 million; this financial measure supplies no headcount, staff-to-resident ratio, turnover rate or evidence of clinical outcomes. Leasing and resident liabilities matter to comparisons: the balance sheet carries $71.564 million borrowings, $141.512 million lease liabilities and $38.906 million refundable occupation-right agreements.
Notes explain the St Allisa acquisition and immediate related-party property sale and leaseback, property valuation assumptions, workforce-related businesses, cash-flow risks and post-balance-date commitments. As of the 13 May authorisation, Karori’s $13.6 million acquisition remained conditional with settlement expected on 26 May. The financial audit covers fair presentation of the statements, not the separate annual narrative, site clinical quality, current care availability or investment suitability.
Read bundled source notes
The saved source file may include fuller notes and references than the indexed summary. Check its dates and evidence limits.
Loading saved source notes…
Document Details & Metadata
Related Resources
109-page FY2026 issuer report on Oceania’s care/village portfolio, resident and workforce measures, audited financial statements, ORA accounting, governance and voluntary climate reporting, with clearly separated adjusted measures and future plans.
42-page FY2026 financial annual report with a short portfolio and leadership overview, audited statements, valuation and resident-loan notes, planned development and limited resident-feedback reporting; separate from the two-page results release.
Two-page issuer results release linking unaudited underlying EBITDA, mixed care-suite/apartment completions and portfolio growth to the year ended March 2026; should be read with the full financial annual report, doc-0194.
Four-page May 2026 issuer release on reported care occupancy, adjusted earnings, planned Karori acquisition, new-build care projects and home-support expansion; forecast capacity and promotional service claims require separate verification.
The report brings together a corporate portfolio overview, strategy, resident experience, workforce and environmental initiatives, audited consolidated financial statements and remuneration/governance reporting. Its accounts report a statutory loss despite improved adjusted operating earnings and positive aggregate free cash flow; the existing-operations component of that cash flow remains negative. Restated FY25 values and the note 2 reconciliation are essential for comparisons. Use the company’s dated care occupancy and portfolio figures to frame questions, with mature-site and cross-country boundaries retained. Organisation-wide team members are not clinical staffing FTE; NPS and participation scores lack detailed survey denominators. Testimonials, product roll-outs and training claims are commercial narrative rather than independently evaluated clinical evidence. Future construction, demographic assertions and dividend/funding expectations require separate subsequent verification.
Report-based reconciliation of a June 2026 source brief. Original authored publication date is known only to year 2026; 5 June dates the annual report, not necessarily the brief. Detailed narrative retains historical strategy and June news context while correcting report contradictions; analyst reaction, subsequent bond events and later role/project outcomes are not independently checked in this scoped review.